" /> Trastuzumab/Pertuzumab/Vinorelbine Regimen - CISMeF





Preferred Label : Trastuzumab/Pertuzumab/Vinorelbine Regimen;

NCIt synonyms : Trastuzumab/Pertuzumab/Vinorelbine; Pertuzumab/Trastuzumab/Vinorelbine; Trastuzumab-Pertuzumab-Vinorelbine Regimen; Trastuzumab-Pertuzumab-Vinorelbine;

NCIt related terms : VHP (trastuzumab-anns); VHP (trastuzumab-dkst); VHP (trastuzumab-dttb); VHP (trastuzumab-pkrb); VHP; VHP (trastuzumab-qyyp); VHP (trastuzumab-zerc); VHP (trastuzumab-herw);

NCIt definition : A regimen consisting of trastuzumab, pertuzumab, and vinorelbine that may be used as a treatment for recurrent and metastatic HER-2 (EGFR2; ErbB2)-positive advanced or metastatic breast cancer.;

NCI Metathesaurus CUI : CL563084;

Codes from synonyms : 75413; 128975; 128878; 129460; 129363; 129266; 129169; 129072;

Details


You can consult :


Nous contacter.
31/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.